← All organizations

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Academic/HospitalWebsite ↗

Also known as: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2025

Timeline

1990s

Nov 1, 1990
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea— Founded

Drugs by trial phase (36 distinct, 28 trials)

Phase 3 (9 own, 0 via acquisition)

Phase 2 (27 own, 0 via acquisition)

Indications

Studied for

Recent trials (30)

NCT07285590Lead sponsorPhase 2Sep 30, 2025
NCT07126236Lead sponsorPhase 2Aug 4, 2025
NCT07254754Lead sponsorPhase 2Nov 20, 2024
NCT06284122CollaboratorPhase 3Jun 7, 2024
NCT04378647Lead sponsorPhase 2Jun 1, 2020
NCT03576378Lead sponsorPhase 1/Phase 2Apr 5, 2018
NCT02682641Lead sponsorPhase 2May 1, 2016
NCT02692248Lead sponsorPhase 2Apr 1, 2016
NCT02267915Lead sponsorPhase 2Mar 1, 2015
NCT02267915Study directorPhase 2Mar 1, 2015
NCT02243436Lead sponsorPhase 1/Phase 2Nov 1, 2014
NCT05049473CollaboratorPhase 2Jan 31, 2014
NCT01848132Lead sponsorPhase 2Oct 3, 2013
NCT02012088Lead sponsorPhase 2Oct 1, 2013
NCT01613300Lead sponsorPhase 2May 1, 2012

Details

Founded: Santander, ES Nov 1, 1990
Last known activity: Sep 30, 2025